Key result
Analysis supports SBP targets <140 mm Hg in low-risk and <130 mm Hg in high-risk patients.
Commentary evaluates risk-stratified systolic blood pressure targets in cardiovascular patients, suggesting caution before widespread clinical implementation.
In an elegant analysis based on benefit-to-hazard ratio, Phillips et al. [(1)][1], suggest an on-treatment systolic blood pressure (SBP) target of <140 mm Hg in low-risk patients and <130 mm Hg in high-risk patients. Before we implement their recommendations to “help providers and patients
No takes yet. Share an insight, caveat, or question.
Messerli et al. (2018) studied this question. On-treatment systolic blood pressure targets of <140 mm Hg in low-risk patients and <130 mm Hg in high-risk patients are suggested based on a benefit-to-hazard analysis.
Synapse has enriched 5 related papers. Consider them for comparative context: